Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Novan Inc | NOVN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.0941 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.0941 | 0.0941 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.082 - 1.3786 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.0941 | USD |
Novan Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 2.64M | - | - | - | -18.68 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Novan News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/25/2024 | 07:54 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/05/2024 | 08:23 | GlobeNewswire Inc. | Novartis expands production of Pluvicto™ with addition of.. |
| 12/10/2023 | 18:30 | GlobeNewswire Inc. | Novartis presents new 48-week results from Phase III.. |
| 12/08/2023 | 08:15 | GlobeNewswire Inc. | Latest Novartis Kisqali® NATALEE analysis reinforces 25%.. |
| 12/05/2023 | 18:16 | GlobeNewswire Inc. | Novartis receives FDA approval for Fabhalta® (iptacopan),.. |
| 11/20/2023 | 00:15 | GlobeNewswire Inc. | Novartis showcases significant data updates from Kisqali®,.. |
| 10/24/2023 | 16:01 | Edgar (US Regulatory) | Form 8-K - Current report |
| 10/20/2023 | 16:00 | Edgar (US Regulatory) | Form 8-K - Current report |
| 9/07/2023 | 15:58 | Edgar (US Regulatory) | Form 8-K - Current report |
| 8/24/2023 | 15:31 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/26/2023 | 15:50 | Edgar (US Regulatory) | Form 8-K - Current report |
| 7/17/2023 | 15:30 | Edgar (US Regulatory) | Form 8-K - Current report |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NOVN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
| 1 Year | 1.26 | 1.3786 | 0.082 | 0.3133186 | 1,130,584 | -1.17 | -92.53% |
| 3 Years | 1.31 | 20.74 | 0.082 | 7.49 | 937,181 | -1.22 | -92.82% |
| 5 Years | 0.8574 | 20.74 | 0.082 | 1.53 | 4,893,961 | -0.7633 | -89.02% |
Novan Description
| Novan Inc is a clinical-stage biotechnology company. It is engaged in developing therapies based on nitric oxide for treating dermatology and oncovirus related diseases. |
